A mutation-agnostic gene therapy approach offers new possibilities for patients, especially those with inherited retinal diseases.
Allen C. Ho, MD, FACS, FASRS
Advertisement
Articles by Allen C. Ho, MD, FACS, FASRS
A mutation-agnostic gene therapy approach offers new possibilities for patients with advanced retinal disease.
Advertisement
Latest Updated Articles
Optogenetics for advanced retinal diseasePublished: November 6th 2025 | Updated:
Optogenetics for retinal diseasePublished: June 16th 2025 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
2
Timely interventions can protect vision in patients with GA
3
Monitoring MacTel: Why BCVA does not tell the whole story
4
Enhancing Durability and Fluid Control with Aflibercept 8 mg in Retinal Vascular Diseases
5
